A.R.T. Advisors’s Cytosorbents Corp CTSO Stock Holding History

A.R.T. Advisors’s Portfolio CTSO Stock Details CTSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,335	Closed	-$216K	–	1361
2018 Q4	$216K	Buy	+1,335	New	+$265K	0.01%	1030
2018 Q3	–	Sell	-582	Closed	-$132K	–	1450
2018 Q2	$132K	Buy	+582	New	+$110K	0.01%	1275
2018 Q1	–	Sell	-532	Closed	-$69K	–	1540
2017 Q4	$69K	Buy	+532	New	+$67.7K	﹤0.01%	1280
2016 Q1	–	Sell	-702	Closed	-$78K	–	1408
2015 Q4	$78K	Buy	+702	New	+$95.6K	﹤0.01%	1350

Other funds holding CTSO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Skylands Capital Milwaukee, Wisconsin $762M AUM 14.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.26% 1-Year Est. Return

Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

United Services Automobile Association San Antonio, Texas $1.24B AUM 2.91% 1-Year Est. Return

Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return

A.R.T. Advisors's CTSO Position: Q1 2019 in Review

A.R.T. Advisors sold out of Cytosorbents Corp (CTSO) in Q1 2019, closing a stake of 1,335 shares — an estimated $216K sold.

A.R.T. Advisors first reported a position in CTSO in Q4 2015 and held it in 4 quarters. The position peaked at $216K in Q4 2018. 77 funds tracked by Wall St. Rank hold CTSO as of Q1 2019.

A.R.T. Advisors reported no remaining Cytosorbents Corp position as of Q1 2019 after selling out during the quarter.
A.R.T. Advisors sold 1,335 Cytosorbents Corp shares in Q1 2019, an estimated $216K.
A.R.T. Advisors first reported a position in Cytosorbents Corp in Q4 2015 and held it in 4 quarters.
A.R.T. Advisors's Cytosorbents Corp position peaked at $216K in Q4 2018.
77 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2019.

Based on A.R.T. Advisors's 13F filing for Q1 2019, filed 15 May 2019.